Profile data is unavailable for this security.
About the company
Henan Lingrui Pharmaceutical Co., Ltd is a China-based company, principally engaged in the research and development, production and distribution of medicines. The Company's products include emplastrum, tablets, capsules, ointments and others, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascular and cerebrovascular diseases, respiratory disease, gynecopathy and dermatopathy, among others. The Company distributes its products throughout China, with Henan Province and Beijing as its major markets.
- Revenue in CNY (TTM)3.56bn
- Net income in CNY675.80m
- Incorporated1999
- Employees2.53k
- LocationHenan Lingrui Pharmaceutical Co LtdNo.666, Jiangjun Road, Xinxian CountyXINYANG 465550ChinaCHN
- Phone+86 3 762973569
- Fax+86 3 762987888
- Websitehttp://www.lingrui.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangxi Tianxin Pharmaceutical Co Ltd | 2.01bn | 557.43m | 11.46bn | 2.47k | 20.58 | 2.57 | -- | 5.71 | 1.27 | 1.27 | 4.58 | 10.18 | 0.3977 | 2.75 | 10.26 | 812,720.60 | 11.04 | -- | 11.82 | -- | 41.64 | -- | 27.76 | -- | 6.39 | -- | 0.0234 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
| KPC Pharmaceuticals Inc | 7.55bn | 446.07m | 11.65bn | 5.05k | 25.98 | 2.11 | -- | 1.54 | 0.5924 | 0.5924 | 10.03 | 7.31 | 0.7819 | 2.75 | 2.56 | 1,494,697.00 | 4.64 | 5.42 | 7.75 | 9.13 | 40.84 | 43.68 | 5.94 | 5.70 | 1.51 | -- | 0.172 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Liaoning Chengda Biotechnology Co Ltd | 1.72bn | 332.10m | 11.66bn | 1.73k | 34.86 | 1.22 | -- | 6.79 | 0.8032 | 0.8032 | 4.16 | 22.93 | 0.1702 | 0.763 | 1.43 | 991,973.80 | 3.29 | 10.63 | 3.41 | 11.01 | 80.53 | 85.74 | 19.33 | 39.56 | 17.44 | -- | 0.0018 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
| Chongqing Genrix Biophrmctcl Co Ltd | 13.56m | -779.42m | 11.69bn | 547.00 | -- | 4.97 | -- | 862.33 | -2.13 | -2.13 | 0.037 | 6.42 | 0.0039 | 0.1009 | 1.37 | 24,790.27 | -22.22 | -- | -23.06 | -- | 55.87 | -- | -5,747.82 | -- | 18.62 | -- | 0.2454 | -- | 154.92 | -- | -39.03 | -- | -- | -- |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.56bn | 675.80m | 12.36bn | 2.53k | 18.16 | 4.27 | -- | 3.47 | 1.20 | 1.20 | 6.34 | 5.10 | 0.7489 | 2.24 | 10.18 | 1,408,620.00 | 14.20 | 10.68 | 23.52 | 16.56 | 72.35 | 74.42 | 18.96 | 14.92 | 0.9579 | -- | 0.0073 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.46bn | 486.79m | 12.49bn | 8.41k | 25.42 | 1.88 | -- | 1.93 | 0.1912 | 0.1912 | 2.54 | 2.59 | 0.618 | 2.39 | 4.56 | 768,224.60 | 4.98 | 6.77 | 6.93 | 10.50 | 51.47 | 63.24 | 8.06 | 11.10 | 1.24 | -- | 0.0781 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
| Tibet Rhodiola Pharmaceutical Holding Co | 2.94bn | 737.44m | 12.58bn | 601.00 | 15.14 | 3.47 | -- | 4.28 | 2.58 | 2.58 | 9.69 | 11.26 | 0.6264 | 1.54 | 6.79 | 4,894,779.00 | 15.80 | 12.44 | 20.83 | 15.71 | 93.36 | 90.51 | 25.22 | 20.43 | 3.44 | 7.74 | 0.1264 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| BrightGene Bio-Medical Technology Co Ltd | 1.24bn | 188.08m | 12.69bn | 1.16k | 67.24 | 5.39 | -- | 10.22 | 0.4466 | 0.4466 | 2.96 | 5.57 | 0.2522 | 1.63 | 3.50 | 1,074,862.00 | 2.91 | 6.53 | 3.57 | 7.93 | 54.97 | 56.93 | 11.55 | 19.90 | 1.18 | 4.53 | 0.4841 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
Data as of Sep 13 2024. Currency figures normalised to Henan Lingrui Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
20.96%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 32.81m | 5.59% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2024 | 32.21m | 5.49% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 17.45m | 2.98% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 8.82m | 1.50% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 8.35m | 1.42% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 8.10m | 1.38% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 5.09m | 0.87% |
| Oriental Alpha Fund Management Co. Ltd.as of 30 Jun 2024 | 4.35m | 0.74% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 3.06m | 0.52% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 2.69m | 0.46% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
